Behavioral treatment of hyperlipidemia: Techniques, results, and future directions

Timothy P. Carmody, Steven G. Fey, Diane K. Pierce, William E. Connor, Joseph Matarazzo

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The present review examines the role of several target behaviors in the treatment of hyperlipidemia, including diet, exercise, cigarette smoking, Type A pattern, and medication adherence. Modification of the typical American diet (high in cholesterol, fat, and sodium) is emphasized in the treatment of hyperlipidemia since a multitude of laboratory, clinical, and epidemiological studies have shown that diet plays a crucial role in the pathogenesis of this condition and an increase in coronary risk. Factors affecting patient compliance such as health beliefs and family support are discussed in terms of their impact on behavior change efforts aimed at reducing plasma lipids through dietary and drug regimens. Intervention studies are reviewed in the behavioral treatment of hyperlipidemia. These programs have focused on diet modification, exercise, and medication adherence to reduce plasma lipids and coronary risk. The role of other target behaviors (i.e., Type A pattern and smoking) is explored not only in determining coronary risk but also in terms of their direct impact on plasma lipids. Further research is necessary to clarify the relationship between these target behaviors and plasma lipid levels and to investigate the effects of innovative family- and group-based intervention procedures in promoting and maintaining habit change related to coronary risk reduction.

Original languageEnglish (US)
Pages (from-to)91-116
Number of pages26
JournalJournal of Behavioral Medicine
Volume5
Issue number1
DOIs
StatePublished - Mar 1982

Fingerprint

Hyperlipidemias
Lipids
Medication Adherence
Diet
Smoking
Diet Therapy
Family Health
Risk Reduction Behavior
Therapeutics
Patient Compliance
Habits
Epidemiologic Studies
Sodium
Fats
Cholesterol
Direction compound
Research
Pharmaceutical Preparations

Keywords

  • behavioral intervention
  • compliance
  • hyperlipidemia

ASJC Scopus subject areas

  • Clinical Psychology
  • Psychology(all)

Cite this

Carmody, T. P., Fey, S. G., Pierce, D. K., Connor, W. E., & Matarazzo, J. (1982). Behavioral treatment of hyperlipidemia: Techniques, results, and future directions. Journal of Behavioral Medicine, 5(1), 91-116. https://doi.org/10.1007/BF00845259

Behavioral treatment of hyperlipidemia : Techniques, results, and future directions. / Carmody, Timothy P.; Fey, Steven G.; Pierce, Diane K.; Connor, William E.; Matarazzo, Joseph.

In: Journal of Behavioral Medicine, Vol. 5, No. 1, 03.1982, p. 91-116.

Research output: Contribution to journalArticle

Carmody, TP, Fey, SG, Pierce, DK, Connor, WE & Matarazzo, J 1982, 'Behavioral treatment of hyperlipidemia: Techniques, results, and future directions', Journal of Behavioral Medicine, vol. 5, no. 1, pp. 91-116. https://doi.org/10.1007/BF00845259
Carmody, Timothy P. ; Fey, Steven G. ; Pierce, Diane K. ; Connor, William E. ; Matarazzo, Joseph. / Behavioral treatment of hyperlipidemia : Techniques, results, and future directions. In: Journal of Behavioral Medicine. 1982 ; Vol. 5, No. 1. pp. 91-116.
@article{7e514c15b88f47478ec924e87a32a3a1,
title = "Behavioral treatment of hyperlipidemia: Techniques, results, and future directions",
abstract = "The present review examines the role of several target behaviors in the treatment of hyperlipidemia, including diet, exercise, cigarette smoking, Type A pattern, and medication adherence. Modification of the typical American diet (high in cholesterol, fat, and sodium) is emphasized in the treatment of hyperlipidemia since a multitude of laboratory, clinical, and epidemiological studies have shown that diet plays a crucial role in the pathogenesis of this condition and an increase in coronary risk. Factors affecting patient compliance such as health beliefs and family support are discussed in terms of their impact on behavior change efforts aimed at reducing plasma lipids through dietary and drug regimens. Intervention studies are reviewed in the behavioral treatment of hyperlipidemia. These programs have focused on diet modification, exercise, and medication adherence to reduce plasma lipids and coronary risk. The role of other target behaviors (i.e., Type A pattern and smoking) is explored not only in determining coronary risk but also in terms of their direct impact on plasma lipids. Further research is necessary to clarify the relationship between these target behaviors and plasma lipid levels and to investigate the effects of innovative family- and group-based intervention procedures in promoting and maintaining habit change related to coronary risk reduction.",
keywords = "behavioral intervention, compliance, hyperlipidemia",
author = "Carmody, {Timothy P.} and Fey, {Steven G.} and Pierce, {Diane K.} and Connor, {William E.} and Joseph Matarazzo",
year = "1982",
month = "3",
doi = "10.1007/BF00845259",
language = "English (US)",
volume = "5",
pages = "91--116",
journal = "Journal of Behavioral Medicine",
issn = "0160-7715",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Behavioral treatment of hyperlipidemia

T2 - Techniques, results, and future directions

AU - Carmody, Timothy P.

AU - Fey, Steven G.

AU - Pierce, Diane K.

AU - Connor, William E.

AU - Matarazzo, Joseph

PY - 1982/3

Y1 - 1982/3

N2 - The present review examines the role of several target behaviors in the treatment of hyperlipidemia, including diet, exercise, cigarette smoking, Type A pattern, and medication adherence. Modification of the typical American diet (high in cholesterol, fat, and sodium) is emphasized in the treatment of hyperlipidemia since a multitude of laboratory, clinical, and epidemiological studies have shown that diet plays a crucial role in the pathogenesis of this condition and an increase in coronary risk. Factors affecting patient compliance such as health beliefs and family support are discussed in terms of their impact on behavior change efforts aimed at reducing plasma lipids through dietary and drug regimens. Intervention studies are reviewed in the behavioral treatment of hyperlipidemia. These programs have focused on diet modification, exercise, and medication adherence to reduce plasma lipids and coronary risk. The role of other target behaviors (i.e., Type A pattern and smoking) is explored not only in determining coronary risk but also in terms of their direct impact on plasma lipids. Further research is necessary to clarify the relationship between these target behaviors and plasma lipid levels and to investigate the effects of innovative family- and group-based intervention procedures in promoting and maintaining habit change related to coronary risk reduction.

AB - The present review examines the role of several target behaviors in the treatment of hyperlipidemia, including diet, exercise, cigarette smoking, Type A pattern, and medication adherence. Modification of the typical American diet (high in cholesterol, fat, and sodium) is emphasized in the treatment of hyperlipidemia since a multitude of laboratory, clinical, and epidemiological studies have shown that diet plays a crucial role in the pathogenesis of this condition and an increase in coronary risk. Factors affecting patient compliance such as health beliefs and family support are discussed in terms of their impact on behavior change efforts aimed at reducing plasma lipids through dietary and drug regimens. Intervention studies are reviewed in the behavioral treatment of hyperlipidemia. These programs have focused on diet modification, exercise, and medication adherence to reduce plasma lipids and coronary risk. The role of other target behaviors (i.e., Type A pattern and smoking) is explored not only in determining coronary risk but also in terms of their direct impact on plasma lipids. Further research is necessary to clarify the relationship between these target behaviors and plasma lipid levels and to investigate the effects of innovative family- and group-based intervention procedures in promoting and maintaining habit change related to coronary risk reduction.

KW - behavioral intervention

KW - compliance

KW - hyperlipidemia

UR - http://www.scopus.com/inward/record.url?scp=0020326422&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020326422&partnerID=8YFLogxK

U2 - 10.1007/BF00845259

DO - 10.1007/BF00845259

M3 - Article

C2 - 7120380

AN - SCOPUS:0020326422

VL - 5

SP - 91

EP - 116

JO - Journal of Behavioral Medicine

JF - Journal of Behavioral Medicine

SN - 0160-7715

IS - 1

ER -